A photo of William Brinkman.

Director, Division of General and Community Pediatrics, Carl Weihl Professor of Pediatrics

Member, Center for ADHD

Member, Center for Innovation in Chronic Disease Care

Professor, UC Department of Pediatrics


My Biography & Research


William B. Brinkman, MD, MEd, MSc, is the Carl Weihl Professor of Pediatrics and Director of the Division of General & Community Pediatrics. Dr. Brinkman leads a diverse, talented, multidisciplinary team who share a passion and commitment to transform the delivery of primary care and improve population health through exceptional clinical programs, high-impact clinical and translational research, innovative educational programs, and effective academic and community partnerships.

Clinical Interests

Shared decision making; knowledge translation; family centered care; quality improvement; implementation science; attention-deficit/hyperactivity disorder (ADHD); asthma; family/self-management of chronic conditions

Academic Affiliation

Professor, UC Department of Pediatrics


Hospital Medicine, Primary Care, Attention Deficit Hyperactivity Disorder ADHD, Attention Deficit Hyperactivity Disorder ADHD, Hospital Medicine, General and Community Pediatrics, General and Community Pediatrics

My Education

MD: St. Louis University, St. Louis, MO, 1999.

Residency: Pediatrics, The Children's Memorial Hospital, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2002.

Chief Residency: Pediatrics, The Children's Memorial Hospital, Chicago, IL, 2003.

Fellowship: NRSA Primary Care Research Fellowship, General & Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2006.

MEd: University of Cincinnati, Cincinnati, OH, 2006.

MSc: University of Cincinnati, Cincinnati, OH, 2013.

Certification: Pediatrics, 2002.

My Publications

Crosby LE, Walton, A, Shook LM, Ware RE, Treadwell, M, Saving KL, Peugh J, McTate E, Oyeku S, Nwankwo C, Brinkman WB. Development of a Hydroxyurea Decision Aid for Parents of Children with Sickle Cell Anemia. J Pediatr Hematol Oncol. 2019 Jan;41(1):56-63.

McGowan M, Prows C, Brinkman W, Vaughn L, DeJonckheere M, Myers M. Adolescent and Parental Attitudes about Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences. J Empir Res Hum Res Ethics. 2018 Oct;13(4):371-382.

Brinkman WB, Sucharew H, Hartl Majcher J, Epstein JN. Predictors of Medication Continuity in Children with ADHD. Pediatrics. 2018 Jun;141(6):e20172580.

Anixt JS, Meinzen-Derr J, Estridge H, Smith L, Brinkman WB. Characteristics of treatment decisions to address challenging behaviors in children with autism spectrum disorder (ASD). J Dev Behav Pediatr. 2018 May;39(4):282-291.

Froehlich TE, Brinkman WB. Multimodal Treatment of the School-aged Child with Attention-Deficit/Hyperactivity Disorder. JAMA Pediatr. 2018 Feb 1;172(2):109-110.

Brinkman WB, Simon JO, Epstein JN. Reasons Why Children and Adolescents with ADHD Stop and Restart Taking Medicine. Acad Pediatr. 2018 Apr;18(3):273-280.

Brinkman WB, Lipstein EA, Taylor J, Schoettker PJ, Naylor K, Jones K, Vora SS, Mims CC, Roth-Wojcicki E, Gottlieb B, Griffin N, Lannon C, Morgan E. Design and Implementation of a Decision Aid for Juvenile Idiopathic Arthritis Medication Choices. Pediatr Rheumatol Online J. 2017 Jun 5;15(1):48. 

Brinkman WB, Baum R, Kelleher KJ, Peugh J, Gardner W, Lichtenstein P, Langberg J Epstein JN. Relationship between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity. J Am Acad Child Adolesc Psychiatry. 2016; 55(4):289–294.

Brinkman WB, Epstein JN, Auinger P, Tamm L, Froehlich TE. Association of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder with Early Onset Tobacco and Alcohol Use in a National Sample of Young Adolescents. Drug Alcohol Depend. 2015 Feb 1;147:183-9.

Brinkman WB, Hartl Majcher J, Poling L, Shi G, Zender M, Sucharew H, Britto MT, Epstein JN. Shared Decision-Making to Improve Attention-Deficit/Hyperactivity Disorder Care. Patient Educ Couns. 93 (2013) 95–101.